TY  - JOUR

T1  - nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial

JO  - BREAST CANCER RES TR

PY  - 2010/02/01

AU  - Dranitsaris G

AU  - Coleman R

AU  - Gradishar W

ED  - 

DO  - DOI: 10.1007/s10549-009-0424-z

VL  - 119

IS  - 3

SP  - 717

EP  - 724

Y2  - 2025/10/10

ER  -